US Food and Drug Administration Approval Overview in Metastatic Breast Cancer

Lignende værker

• U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
  af: Ning, Yang-Min, et al.
  Udgivet: (2015)
• U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
  af: Herndon, Thomas M., et al.
  Udgivet: (2012)
• U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy
  af: Larkins, Erin, et al.
  Udgivet: (2015)
• US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments
  af: Wedam, Suparna B., et al.
  Udgivet: (2018)
• FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
  af: Blumenthal, Gideon M., et al.
  Udgivet: (2012)